Skip to Content

M LH1 (Hydrochlorothiazide and Lisinopril 12.5 mg / 10 mg)

Pill with imprint M LH1 is White, Round and has been identified as Hydrochlorothiazide and Lisinopril 12.5 mg / 10 mg. It is supplied by Mylan Pharmaceuticals Inc..

Hydrochlorothiazide/lisinopril is used in the treatment of high blood pressure; heart failure and belongs to the drug class ACE inhibitors with thiazides. There is positive evidence of human fetal risk during pregnancy. Hydrochlorothiazide/lisinopril 12.5 mg / 10 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M LH1

Hydrochlorothiazide and lisinopril 12.5 mg / 10 mg M LH1
Hydrochlorothiazide and lisinopril 12.5 mg / 10 mg M LH1
Hydrochlorothiazide and lisinopril 12.5 mg / 10 mg M LH1 Front
Hydrochlorothiazide and lisinopril 12.5 mg / 10 mg M LH1 Back
Hydrochlorothiazide and lisinopril 12.5 mg / 10 mg M LH1
Hydrochlorothiazide and lisinopril 12.5 mg / 10 mg M LH1

Hydrochlorothiazide and Lisinopril

Imprint
M LH1
Strength
12.5 mg / 10 mg
Color
White
Size
9.00 mm
Shape
Round
Availability
Prescription only
Drug Class
ACE inhibitors with thiazides
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
Inactive Ingredients
silicon dioxide, croscarmellose sodium, calcium phosphate dihydrate dibasic, magnesium stearate, mannitol, microcrystalline cellulose, corn starch, sodium lauryl sulfate

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
00378-1012 Mylan Pharmaceuticals Inc.
51079-0697 UDL Laboratories Inc.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.